308 related articles for article (PubMed ID: 23900416)
1. Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt.
Rupprecht LE; Mietlicki-Baase EG; Zimmer DJ; McGrath LE; Olivos DR; Hayes MR
Am J Physiol Endocrinol Metab; 2013 Sep; 305(6):E751-9. PubMed ID: 23900416
[TBL] [Abstract][Full Text] [Related]
2. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.
Hayes MR; Bradley L; Grill HJ
Endocrinology; 2009 Jun; 150(6):2654-9. PubMed ID: 19264875
[TBL] [Abstract][Full Text] [Related]
3. Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation.
Hayes MR; Leichner TM; Zhao S; Lee GS; Chowansky A; Zimmer D; De Jonghe BC; Kanoski SE; Grill HJ; Bence KK
Cell Metab; 2011 Mar; 13(3):320-30. PubMed ID: 21356521
[TBL] [Abstract][Full Text] [Related]
4. Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner.
Zhao S; Kanoski SE; Yan J; Grill HJ; Hayes MR
Int J Obes (Lond); 2012 Dec; 36(12):1522-8. PubMed ID: 22249232
[TBL] [Abstract][Full Text] [Related]
5. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
Burmeister MA; Ayala J; Drucker DJ; Ayala JE
Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
[TBL] [Abstract][Full Text] [Related]
6. Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance.
Reiner DJ; Mietlicki-Baase EG; McGrath LE; Zimmer DJ; Bence KK; Sousa GL; Konanur VR; Krawczyk J; Burk DH; Kanoski SE; Hermann GE; Rogers RC; Hayes MR
J Neurosci; 2016 Mar; 36(12):3531-40. PubMed ID: 27013681
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats.
Xie Z; Enkhjargal B; Wu L; Zhou K; Sun C; Hu X; Gospodarev V; Tang J; You C; Zhang JH
Neuropharmacology; 2018 Jan; 128():142-151. PubMed ID: 28986282
[TBL] [Abstract][Full Text] [Related]
8. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
Zhao H; Wang L; Wei R; Xiu D; Tao M; Ke J; Liu Y; Yang J; Hong T
Diabetes Obes Metab; 2014 Sep; 16(9):850-60. PubMed ID: 24641303
[TBL] [Abstract][Full Text] [Related]
9. Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding.
Alhadeff AL; Grill HJ
Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(4):R465-70. PubMed ID: 24944243
[TBL] [Abstract][Full Text] [Related]
10. Paraventricular Thalamic Control of Food Intake and Reward: Role of Glucagon-Like Peptide-1 Receptor Signaling.
Ong ZY; Liu JJ; Pang ZP; Grill HJ
Neuropsychopharmacology; 2017 Nov; 42(12):2387-2397. PubMed ID: 28811669
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal GLP-1 receptors influence food intake, meal size, and effort-based responding for food through volume transmission.
Hsu TM; Hahn JD; Konanur VR; Lam A; Kanoski SE
Neuropsychopharmacology; 2015 Jan; 40(2):327-37. PubMed ID: 25035078
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
13. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
[TBL] [Abstract][Full Text] [Related]
14. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation.
Hayes MR; Skibicka KP; Grill HJ
Endocrinology; 2008 Aug; 149(8):4059-68. PubMed ID: 18420740
[TBL] [Abstract][Full Text] [Related]
15. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
[TBL] [Abstract][Full Text] [Related]
16. Hindbrain cocaine- and amphetamine-regulated transcript induces hypothermia mediated by GLP-1 receptors.
Skibicka KP; Alhadeff AL; Grill HJ
J Neurosci; 2009 May; 29(21):6973-81. PubMed ID: 19474324
[TBL] [Abstract][Full Text] [Related]
17. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase.
Yusta B; Estall J; Drucker DJ
J Biol Chem; 2002 Jul; 277(28):24896-906. PubMed ID: 11978789
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling.
Mietlicki-Baase EG; Ortinski PI; Reiner DJ; Sinon CG; McCutcheon JE; Pierce RC; Roitman MF; Hayes MR
J Neurosci; 2014 May; 34(20):6985-92. PubMed ID: 24828651
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Glucagon-like Peptide-1 Receptor Signaling in the Nucleus Tractus Solitarius is Required for Food Intake Control.
Alhadeff AL; Mergler BD; Zimmer DJ; Turner CA; Reiner DJ; Schmidt HD; Grill HJ; Hayes MR
Neuropsychopharmacology; 2017 Jun; 42(7):1471-1479. PubMed ID: 27782127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
